Kingdom Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53K Buy
1,441
+640
+80% +$30.3K 0.02% 270
2025
Q4
$40.8K Buy
+801
New +$41K 0.01% 279

Other funds holding NVO

Kingdom Financial Group's NVO Position: Q1 2026 in Review

Kingdom Financial Group increased its Novo Nordisk (NVO) stake by 80% in Q1 2026, buying an estimated $30.3K and bringing the position to 1,441 shares worth $53K. The position accounts for 0.02% of the portfolio, ranked #270.

Kingdom Financial Group first reported a position in NVO in Q4 2025 and has held it in 2 quarters since. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Kingdom Financial Group held 1,441 shares of Novo Nordisk worth $53K as of Q1 2026.
  • Kingdom Financial Group bought 640 Novo Nordisk shares in Q1 2026, an estimated $30.3K.
  • Novo Nordisk made up 0.02% of Kingdom Financial Group's portfolio in Q1 2026, its #270 holding.
  • Kingdom Financial Group first reported a position in Novo Nordisk in Q4 2025 and has held it in 2 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Kingdom Financial Group's 13F filing for Q1 2026, filed 13 May 2026.